CD274 and breast cancer: Pharmacologic mTORC1 inhibition using rapamycin was less effective in PD‐L1KO versus control MB49 cells suggesting that this generally poorly effective treatment strategy might be more effective in BC tumors with low PD‐L1 expression, or paradoxically, low mTORC1 signaling.